Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) EPS (Basic) (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed EPS (Basic) for 15 consecutive years, with -$0.32 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Basic) fell 146.15% year-over-year to -$0.32, compared with a TTM value of -$1.46 through Sep 2025, down 1.39%, and an annual FY2024 reading of -$1.16, up 53.04% over the prior year.
  • EPS (Basic) was -$0.32 for Q3 2025 at BioRestorative Therapies, down from -$0.3 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.39 in Q3 2023 and bottomed at -$30.3 in Q3 2021.
  • Average EPS (Basic) over 5 years is -$3.84, with a median of -$0.64 recorded in 2025.
  • The sharpest move saw EPS (Basic) crashed 1411236.45% in 2021, then skyrocketed 192.67% in 2023.
  • Year by year, EPS (Basic) stood at -$6.99 in 2021, then surged by 83.12% to -$1.18 in 2022, then skyrocketed by 60.17% to -$0.47 in 2023, then soared by 57.45% to -$0.2 in 2024, then plummeted by 60.0% to -$0.32 in 2025.
  • Business Quant data shows EPS (Basic) for BRTX at -$0.32 in Q3 2025, -$0.3 in Q2 2025, and -$0.64 in Q1 2025.